Analyst firms · Piper Sandler · BBWI

Piper Sandler BBWI price target and rating history

Bath & Body Works Inc. (BBWI) · Consumer Discretionary

Piper Sandler rates Bath & Body Works Inc. (BBWI) Neutral with a $20 price target, as of its latest action on May 15, 2026. It has published 4 rating actions on BBWI since June 2022, including 1 upgrade and 1 downgrade. Across 9 firms with a BBWI price target in the last 12 months, the median target is $20. Piper Sandler's target matches it.

Current rating
Neutral
Price target
$20
Median target, all firms
$20
Actions on BBWI
4

Piper Sandler price target on BBWI

$58$39$202023202420252026
Piper Sandler price target on BBWI, each point a stated target, June 2022 to May 2026.

Every Piper Sandler rating on BBWI

How other firms rate BBWI

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
BMO Capital MarketsMarket Perform$20Sep 9, 2026
CitigroupBuy$25Aug 18, 2026
Goldman SachsSell$19Jul 8, 2026
Telsey Advisory GroupMarket Perform$22May 28, 2026
Piper SandlerNeutral$20May 15, 2026
JefferiesHold$24Jan 14, 2026
Deutsche BankHold$21Jan 8, 2026
GuggenheimNeutralDec 10, 2025
Robert W. BairdNeutral$19Nov 21, 2025
Morgan StanleyEqual-Weight$18Nov 21, 2025

Questions about Piper Sandler and BBWI

What is Piper Sandler's price target for BBWI?
Piper Sandler's latest stated price target for Bath & Body Works Inc. (BBWI) is $20, from its action on May 15, 2026.
What is Piper Sandler's rating on BBWI?
Piper Sandler rates BBWI Neutral, a neutral rating, as of May 15, 2026.
When did Piper Sandler last change its view on BBWI?
On May 15, 2026, Piper Sandler resumes coverage at Neutral, price target $20.
How does Piper Sandler's BBWI target compare with other analysts?
Across 9 firms with a BBWI price target in the last 12 months, the median target is $20. Piper Sandler's target matches it.

More BBWI rating histories

All Piper Sandler ratingsBBWI news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.